Carl Zeiss Meditec AG
XETRA:AFX
Carl Zeiss Meditec AG
XETRA:AFX
Price:
23.38
EUR
-0.85%
Market Closed
Market Cap:
€2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Carl Zeiss Meditec AG
XETRA:AFX
|
DE |
|
A
|
Alco Holdings Ltd
HKEX:328
|
HK |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
ID |
|
Trulieve Cannabis Corp
OTC:TCNNF
|
US |
|
Youdao Inc
NYSE:DAO
|
CN |
|
Reward Minerals Ltd
ASX:RWD
|
AU |
|
Shikibo Ltd
TSE:3109
|
JP |
|
Changshu Fengfan Power Equipment Co Ltd
SSE:601700
|
CN |
|
B
|
Brilliant Earth Group Inc
NASDAQ:BRLT
|
US |
|
Fuji Soft Service Bureau Inc
TSE:6188
|
JP |
|
Mini Diamonds (India) Ltd
BSE:523373
|
IN |
|
Glory Ltd
TSE:6457
|
JP |
|
G
|
GR Properties Ltd
HKEX:108
|
HK |
|
A
|
Astron Corp Ltd
ASX:ATR
|
AU |
|
Playmates Toys Ltd
HKEX:869
|
HK |
|
I
|
Investeko SA
WSE:IVE
|
PL |
|
Middle East Healthcare Company SJSC
SAU:4009
|
SA |
|
S
|
SolidusGold Inc
XTSX:SDC
|
CA |
|
Freight Technologies Inc
NASDAQ:FRGT
|
US |
|
V
|
Volue ASA
OSE:VOLUE
|
NO |
Relative Value
The Relative Value of one
AFX
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 23.38 EUR,
Carl Zeiss Meditec AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AFX Relative Value
HIDDEN
Multiples Across Competitors
AFX Competitors Multiples
Carl Zeiss Meditec AG Competitors
Carl Zeiss Meditec AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Carl Zeiss Meditec AG
XETRA:AFX
|
2.1B EUR | 0.9 | 16.8 | 7.9 | 13 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.1B USD | 4.1 | 28.1 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.7B USD | 16.9 | 59.4 | 45.1 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.4B USD | 5.1 | 39.6 | 20.2 | 24.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 3.1 | 24 | 13.3 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 7.9 | 44.7 | 24.6 | 26.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.4 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.9B USD | 2 | 25 | 9.9 | 16.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
